688656.SS SHH
HOB Biotech Group Corp.,Ltd
1W: +12.1%
1M: +36.6%
3M: +26.6%
YTD: -7.5%
1Y: +17.7%
3Y: +288.9%
5Y: +71.8%
¥131.72 ($19.64)
-0.31 (-0.23%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$931M
-9.8% ▼
5Y CAGR: +25.7%
Total Liabilities
$111M
-49.6% ▼
5Y CAGR: +4.3%
Shareholders Equity
$820M
+1.0% ▲
5Y CAGR: +31.8%
Cash & Investments
$63M
-47.9% ▼
5Y CAGR: +1.5%
Total Debt
$46M
-59.7% ▼
5Y CAGR: +1.0%
Net Debt
-$17M
-144.2% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $450M | $154M | $163M | $122M | $63M |
| Short-Term Investments | $5M | $135M | $0 | $0 | $0 |
| Cash & ST Investments | $455M | $289M | $163M | $122M | $63M |
| Net Receivables | $37M | $35M | $45M | $51M | $57M |
| Inventory | $68M | $88M | $111M | $111M | $107M |
| Other Current Assets | $14M | $6M | $0 | $1M | $1M |
| Total Current Assets | $570M | $423M | $328M | $292M | $236M |
| Property, Plant & Equip. | $260M | $485M | $579M | $706M | $668M |
| Goodwill & Intangibles | $12M | $13M | $12M | $10M | $11M |
| Long-Term Investments | $11M | $98K | $0 | $0 | $0 |
| Other Non-Current Assets | $9M | $22M | $28M | $21M | $15M |
| Total Non-Current Assets | $294M | $522M | $621M | $741M | $696M |
| Total Assets | $864M | $945M | $949M | $1.0B | $931M |
| — Liabilities — | |||||
| Accounts Payable | $11M | $48M | $24M | $45M | $14M |
| Short-Term Debt | $20M | $50M | $50M | $105M | $45M |
| Deferred Revenue | $44M | $13M | $0 | $0 | $0 |
| Other Current Liabilities | $19M | $53M | $20M | $57M | $16M |
| Total Current Liabilities | $86M | $153M | $136M | $210M | $109M |
| Long-Term Debt | $0 | $0 | $0 | $8M | $0 |
| Other Non-Current Liab. | $2M | $2M | $0 | $0 | $0 |
| Total Non-Current Liabilities | $8M | $12M | $3M | $11M | $3M |
| Total Liabilities | $94M | $165M | $139M | $221M | $111M |
| — Equity — | |||||
| Common Stock | $63M | $63M | $63M | $63M | $63M |
| Retained Earnings | $131M | $134M | $162M | $174M | $179M |
| Accumulated OCI | $26M | $33M | $0 | $0 | $0 |
| Total Stockholders Equity | $770M | $780M | $811M | $812M | $820M |
| Total Liabilities & Equity | $864M | $945M | $949M | $1.0B | $931M |
| — Key Metrics — | |||||
| Total Debt | $31M | $65M | $51M | $115M | $46M |
| Net Debt | -$419M | -$88M | -$112M | -$7M | -$17M |
| Total Investments | $5M | $135M | $0 | $0 | $0 |